Gene Therapy - Shenzhen Genoimmune Medical Institute

Gene Therapy

Trial title

Estimated Enrollment

Partner
Trial title

Lentiviral FVIII Gene Therapy for Hemophilia A' NCT03217032

Estimated Enrollment

10

Partner
- Shenzhen Geno-immune Medical Institute
Trial title

Gene Therapy of Beta Thalathemia Using a Self-inactivating Lentiviral Vector' NCT03351829

Estimated Enrollment

20

Partner
- Shenzhen Geno-immune Medical Institute
Trial title

Phase I/II Multicenter Trial of Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections' NCT03159364

Estimated Enrollment

100

Partner
- Shenzhen Geno-immune Medical Institute
Trial title

Gene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1) Using a Self Lentiviral Vector' NCT03217617

Estimated Enrollment

10

Partner
- Shenzhen Geno-immune Medical Institute
- Beijing Children's Hospital
- Capital Institute of Pediatrics affiliated Children's hospital
Trial title

FANC-A Gene Transfer for Fanconi Anemia Using a Self-inactivating Lentiviral Vector' NCT03351868

Estimated Enrollment

10

Partner
- Shenzhen Geno-immune Medical Institute
- Beijing Children's Hospital
- Capital Institute of Pediatrics affiliated Children's hospital
Trial title

Gene Transfer for Adenosine Deaminase-severe Combined Immunodeficiency (ADA-SCID) Using an Improved Self-inactivating Lentiviral Vector (TYF-ADA)' NCT03645460

Estimated Enrollment

10

Partner
- Shenzhen Geno-immune Medical Institute
Trial title

Lentiviral Gene Therapy for Chronic Granulomatous Disease (CGD)' NCT03645486

Estimated Enrollment

10

Partner
- Shenzhen Geno-immune Medical Institute
Trial title

Gene Therapy for Metachromatic Leukodystrophy (MLD) Using a Self-inactivating Lentiviral Vector (TYF-ARSA)' NCT03725670

Estimated Enrollment

10

Partner
- Shenzhen Geno-immune Medical Institute
Trial title

Lentiviral Gene Therapy for X-linked Adrenoleukodystrophy (X-ALD)' NCT03727555

Estimated Enrollment

10

Partner
- Shenzhen Geno-immune Medical Institute
Trial title

Lentiviral FIX Gene Therapy for Hemophilia B' NCT03961243

Estimated Enrollment

10

Partner
- Shenzhen Geno-immune Medical Institute